Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer EnLite NeoNatal TREC Kit

PerkinElmer announced the commercial availability in the US and Canada of the EnLite Neonatal TREC Kit, a screening test for Severe Combined Immunodeficiency (SCID), also known more commonly as “Bubble Boy” disease. PerkinElmer has received market authorization from the FDA and from Health Canada to offer the test, which provides a semi-quantitative determination of T-cell receptor excision circle (TREC), a circular DNA structure which is the primary identifiable marker for SCID. The test identifies newborns for confirmatory testing which leads to diagnosis.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.